Rallybio

Rally car race swerve crash

Biotech

Rallybio swerves past Candid pothole to land deal with Avenzo

Rallybio has steered its way to a new merger, inking a deal with Avenzo Therapeutics weeks after a UCB buyout took its former partner off the market.

Nick Paul Taylor Jun 1, 2026 9:09am

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

UCB inks $2B Candid buyout to join Gilead in autoimmune field

May 4, 2026 7:46am

two arrows pointing different directions

Candid scores Nasdaq listing via reverse merger Rallybio

Mar 2, 2026 11:45am

relay

Rallybio shifts gears, cashing out of Recursion pact

Jul 8, 2025 8:59am

scissor cutting rope

RallyBio cuts deeper, laying off 40% of workforce

May 8, 2025 9:00am

crash fall stock shares market economy down red arrow

Rallybio drops lead program as phase 2 data disappoint

Apr 8, 2025 8:52am